MedTrace Logo

SeeMe: An Automated Tool to Detect Early Recovery After Brain Injury

NCT06083441 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-10-16

No results posted yet for this study

Summary

Early prediction of outcomes after acute brain injury (ABI) remains a major unsolved problem. Presently, physicians make predictions using clinical examination, traditional scoring systems, and statistical models. In this study, we will use a novel technique, "SeeMe," to objectively assess the level of consciousness in patients suffering from comas following ABI. SeeMe is a program that quantifies total facial motion over time and compares the response after a spoken command (i.e. "open your eyes") to a pre-stimulus baseline.

Conditions

Interventions

DIAGNOSTIC_TEST

SeeMe

A video-recorded SeeMe command following assessment by a trained professional once a day Each session involves three command sets that are played from an audio recording 10 times over the course of 8 minutes. These commands are "Stick out your tongue", "Open your eyes", and "Show me a smile" Each command set is recorded separately for a total of 3 videos per session. These videos are then analyzed by SeeMe to detect if subjects are responding to commands.

DIAGNOSTIC_TEST

Coma Recovery Scale-Revised (CRS-R)

A video-recorded CRS-R score assessment by a trained professional once a day. A score of 10 or greater, an auditory score \>2, or an arousal score \> 0 means that a subject is responding to commands

Sponsors & Collaborators

Principal Investigators

  • Sima Mofakham, PhD · Stony Brook Medicine

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-16
Primary Completion
2025-06-30
Completion
2025-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06083441 on ClinicalTrials.gov